How U.S. foreign investment policies could reshape NRI investment patterns in Indian real estate

As U.S. foreign investment and immigration policies face potential tightening, particularly under a possible Trump administration, Non-Resident Indians (NRIs) are reconsidering their financial strategies. Industry leaders point to a notable shift in NRI investment behaviors, with many looking to Indian real estate as a safe and lucrative alternative.

Key players in the real estate sector highlight several converging factors driving this trend. These include rising uncertainty around U.S. work visas and foreign investments, the depreciation of the rupee, and India’s streamlined real estate investment frameworks.

NRIs are increasingly focusing on premium commercial properties and luxury residential markets in cities like Mumbai, Delhi-NCR, Bangalore, and Hyderabad. This transition reflects not only financial prudence but also a desire for long-term security amidst global uncertainties. Additionally, advancements in India’s regulatory landscape and digital transaction platforms are making cross-border investments more seamless than ever before.

Also Read: Smart strategies for tenants to cut costs on rent payments

Siddharth Maurya, Founder & Managing Director of Vibhavangal Anukulakara Private Limited, says, the anticipated return of Trump, coupled with stringent US policies, could potentially bolster the Indian real estate market.

“We are observing a dual trend where NRIs are investing not solely for financial returns but also to establish contingency plans. NRIs are increasingly concentrating on Grade A commercial properties and the luxury residential sectors in Mumbai, Delhi-NCR, and Bangalore. Recent modifications in India’s regulatory framework for real estate, along with the development of online platforms for transactions, have made it easier for NRIs to invest from overseas, thereby contributing to this trend,” Maurya says.

Manoj Goyal, Director, Forteasia Realty Pvt Ltd, says, “The tightening of H1B visa regulations and work permits under the Trump administration could lead to a rise in NRI investments in Indian real estate. This trend is likely due to the uncertainty surrounding U.S. immigration policies, prompting NRIs to repatriate their funds and invest them back in India. Notably, there has already been a 15 percent increase in inquiries from NRIs regarding luxury residential properties in metropolitan areas. Additionally, the depreciation of the rupee has made it more advantageous for NRIs to invest in Indian real estate, allowing them to achieve significant savings on property purchases.”

A clear trend has emerged under the Trump administration,

 » Read More

Related Articles

Trump tariff impact: Pharma stocks surge over 4% on tariff exemption

It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are rallying smartly. In a major relief, Indian pharmaceutical companies breathed a sigh of relief after US President Donald

Trump tariff impact: Tech stocks plummet, Nifty IT cracks 2.5%

The share price of IT stocks slumped after US President Donald Trump’s administration imposed 26% reciprocal tariffs on Indian imports to the US. The Nifty IT, a basket of Indian tech stocks, fell 2.5% to 35,371.55 levels.  All the constituents of the sectoral index were trading in the red. The share price of Persistent Systems

Trump tariffs send shockwaves across global markets; US futures crash, gold soars to new highs- 10 cues you need to track now

Indian stock markets are set for a turbulent start as global jitters over Trump’s new tariffs weigh on. Early trends from GIFT Nifty point to a sharp drop of over 350 points, signaling a weak opening for Sensex and Nifty 50. Indian stock markets ended on a positive note in the previous trading session, with

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Trump tariff impact: Pharma stocks surge over 4% on tariff exemption

It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are rallying smartly. In a major relief, Indian pharmaceutical companies breathed a sigh of relief after US President Donald

Trump tariff impact: Tech stocks plummet, Nifty IT cracks 2.5%

The share price of IT stocks slumped after US President Donald Trump’s administration imposed 26% reciprocal tariffs on Indian imports to the US. The Nifty IT, a basket of Indian tech stocks, fell 2.5% to 35,371.55 levels.  All the constituents of the sectoral index were trading in the red. The share price of Persistent Systems

Trump tariffs send shockwaves across global markets; US futures crash, gold soars to new highs- 10 cues you need to track now

Indian stock markets are set for a turbulent start as global jitters over Trump’s new tariffs weigh on. Early trends from GIFT Nifty point to a sharp drop of over 350 points, signaling a weak opening for Sensex and Nifty 50. Indian stock markets ended on a positive note in the previous trading session, with

‘Pramerica Life targets Rs 3,000-crore GWP in FY26,’ Pankaj Gupta

Pramerica Life Insurance, a joint venture between subsidiaries of Piramal Capital and Housing Finance and US-based Prudential Financial Inc, aims to close FY26 with Rs 3,000 crore in gross written premium. In an interview with Narayanan V, managing director and CEO Pankaj Gupta discusses the products and distribution strategy. Excerpts: Life insurance premiums have been

Tata small cap fund: Targeting growth at reasonable valuations

Tata Small Cap Fund is a growth-oriented scheme in the Small Cap Fund category that has exhibited a noteworthy track record since its inception and has outpaced many of its prominent peers, thereby rewarding investors with superior risk-adjusted returns. Launched in November 2018, Tata Small Cap Fund aims to invest in stocks of companies that are in growth